News from November 2016

The Pirbright Institute is one of the largest recipients of the Government’s new £120 million fund to fight deadly diseases – winning £1.580 million with its partners, for a joint project to develop a safe and effective livestock vaccine against Rift Valley fever. Rift Valley fever (RVF) is an…

Researchers at The Pirbright Institute have secured almost $1.5 million from the Bill and Melinda Gates Foundation to fund the development of improved foot-and-mouth disease (FMD) vaccines for East Africa. The project, headed by Dr Bryan Charleston, Interim Director and CEO of the Institute will…